Figure 6
Figure 6. LIC heterogeneity in NSG-engrafting AML patient samples. NSG-engrafting AML samples contain at least 2 different subtypes of LSCs responsible for the patient myeloid disease and T-cell lymphoproliferative disorder in NOD/SCID IL2Rγcnull mice.

LIC heterogeneity in NSG-engrafting AML patient samples. NSG-engrafting AML samples contain at least 2 different subtypes of LSCs responsible for the patient myeloid disease and T-cell lymphoproliferative disorder in NOD/SCID IL2Rγcnull mice.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal